{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:37:08Z","timestamp":1790638628062,"version":"4.1.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2021-126961OB-I00"],"award-info":[{"award-number":["PID2021-126961OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PDC2022-133783-I00"],"award-info":[{"award-number":["PDC2022-133783-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RD21\/0017\/0020"],"award-info":[{"award-number":["RD21\/0017\/0020"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RD24\/0014\/0016"],"award-info":[{"award-number":["RD24\/0014\/0016"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019945","name":"Direcci\u00f3 General de Recerca, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2021 SGR 01094"],"award-info":[{"award-number":["2021 SGR 01094"]}],"id":[{"id":"10.13039\/501100019945","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundaci\u00f3 Instituci\u00f3 dels Centres de Recerca de Catalunya"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40291-025-00816-3","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:17:10Z","timestamp":1761848230000},"page":"47-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Evolving Landscape of Stem Cell Therapies for Huntington\u2019s Disease"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6552-5648","authenticated-orcid":false,"given":"Marc","family":"Estarellas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7094-1628","authenticated-orcid":false,"given":"Cinta","family":"Gomis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6829-7670","authenticated-orcid":false,"given":"Josep M.","family":"Canals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"816_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/mds.25717","volume":"29","author":"ER Fisher","year":"2014","unstructured":"Fisher ER, Hayden MR. Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk. Mov Disord. 2014;29:105\u201314. https:\/\/doi.org\/10.1002\/mds.25717.","journal-title":"Mov Disord"},{"key":"816_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1399-0004.2010.01538.x","volume":"80","author":"PJ Morrison","year":"2011","unstructured":"Morrison PJ, Harding-Lester S, Bradley A. Uptake of Huntington disease predictive testing in a complete population. Clin Genet. 2011;80:281\u20136. https:\/\/doi.org\/10.1111\/j.1399-0004.2010.01538.x.","journal-title":"Clin Genet"},{"key":"816_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell. 1993;72:971\u201383. https:\/\/doi.org\/10.1016\/0092-8674(93)90585-E.","journal-title":"Cell"},{"key":"816_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, et al. Huntington disease. Nat Rev Dis Primers. 2015;1:1\u201321. https:\/\/doi.org\/10.1038\/nrdp.2015.5.","journal-title":"Nat Rev Dis Primers"},{"key":"816_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol. 2014;10:204\u201316. https:\/\/doi.org\/10.1038\/nrneurol.2014.24.","journal-title":"Nat Rev Neurol"},{"key":"816_CR6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO. Huntington\u2019s disease. Lancet. 2007;369:218\u201328. https:\/\/doi.org\/10.1016\/S0140-6736(07)60111-1.","journal-title":"Lancet"},{"key":"816_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.parkreldis.2022.02.022","volume":"96","author":"KF van der Zwaan","year":"2022","unstructured":"van der Zwaan KF, Mentink MDC, Jacobs M, Roos RAC, de Bot ST. Huntington\u2019s disease influences employment before and during clinical manifestation: a systematic review. Parkinsonism Relat Disord. 2022;96:100\u20138. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.02.022.","journal-title":"Parkinsonism Relat Disord"},{"key":"816_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/practneurol-2021-003074","volume":"22","author":"TB Stoker","year":"2022","unstructured":"Stoker TB, Mason SL, Greenland JC, Holden ST, Santini H, Barker RA. Huntington\u2019s disease: diagnosis and management. Pract Neurol. 2022;22:32\u201341. https:\/\/doi.org\/10.1136\/practneurol-2021-003074.","journal-title":"Pract Neurol"},{"key":"816_CR9","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","volume":"62","author":"K Duff","year":"2007","unstructured":"Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC. Psychiatric symptoms in Huntington\u2019s disease before diagnosis: the predict-HD study. Biol Psychiatry. 2007;62:1341\u20136. https:\/\/doi.org\/10.1016\/j.biopsych.2006.11.034.","journal-title":"Biol Psychiatry"},{"key":"816_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/a0020937","volume":"25","author":"JC Stout","year":"2011","unstructured":"Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, et al. Neurocognitive signs in prodromal Huntington disease. Neuropsychology. 2011;25:1\u201314. https:\/\/doi.org\/10.1037\/a0020937.","journal-title":"Neuropsychology"},{"key":"816_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","volume":"10","author":"SJ Tabrizi","year":"2011","unstructured":"Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, et al. Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol. 2011;10:31\u201342. https:\/\/doi.org\/10.1016\/S1474-4422(10)70276-3.","journal-title":"Lancet Neurol"},{"key":"816_CR12","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner A, Albin RL, Anderson KD, D\u2019Amato CJ, Penney JB, Young AB. Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A. 1988;85:5733\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"816_CR13","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/brain\/awn025","volume":"131","author":"HD Rosas","year":"2008","unstructured":"Rosas HD, Salat DH, Lee SY, Zaleta AK, Pappu V, Fischl B, et al. Cerebral cortex and the clinical expression of Huntington\u2019s disease: complexity and heterogeneity. Brain. 2008;131:1057\u201368. https:\/\/doi.org\/10.1093\/brain\/awn025.","journal-title":"Brain"},{"key":"816_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3233\/JHD-190372","volume":"8","author":"RY Cheong","year":"2019","unstructured":"Cheong RY, Gabery S, Peters\u00e9n \u00c5. The role of hypothalamic pathology for non-motor features of Huntington\u2019s disease. J Huntingtons Dis. 2019;8:375\u201391. https:\/\/doi.org\/10.3233\/JHD-190372.","journal-title":"J Huntingtons Dis"},{"key":"816_CR15","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/brain\/awac086","volume":"145","author":"AE Rosser","year":"2022","unstructured":"Rosser AE, Busse ME, Gray WP, Badin RA, Perrier AL, Wheelock V, et al. Translating cell therapies for neurodegenerative diseases: Huntington\u2019s disease as a model disorder. Brain. 2022;145:1584\u201397. https:\/\/doi.org\/10.1093\/brain\/awac086.","journal-title":"Brain"},{"key":"816_CR16","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1007\/s10571-023-01344-6","volume":"43","author":"E Cecerska-Hery\u0107","year":"2023","unstructured":"Cecerska-Hery\u0107 E, P\u0119ka\u0142a M, Serwin N, Gli\u017aniewicz M, Grygorcewicz B, Michalczyk A, et al. The use of stem cells as a potential treatment method for selected neurodegenerative diseases: review. Cell Mol Neurobiol. 2023;43:2643\u201373. https:\/\/doi.org\/10.1007\/s10571-023-01344-6.","journal-title":"Cell Mol Neurobiol"},{"key":"816_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093103","volume":"21","author":"R De Gioia","year":"2020","unstructured":"De Gioia R, Biella F, Citterio G, Rizzo F, Abati E, Nizzardo M, et al. Neural stem cell transplantation for neurodegenerative diseases. Int J Mol Sci. 2020;21:3103. https:\/\/doi.org\/10.3390\/ijms21093103.","journal-title":"Int J Mol Sci"},{"key":"816_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213936","volume":"23","author":"DG Lee","year":"2022","unstructured":"Lee DG, Kim Y-K, Baek K-H. The bHLH transcription factors in neural development and therapeutic applications for neurodegenerative diseases. Int J Mol Sci. 2022;23:13936. https:\/\/doi.org\/10.3390\/ijms232213936.","journal-title":"Int J Mol Sci"},{"key":"816_CR19","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/jnnp.73.6.678","volume":"73","author":"AE Rosser","year":"2002","unstructured":"Rosser AE, Barker RA, Harrower T, Watts C, Farrington M, Ho AK, et al. Unilateral transplantation of human primary fetal tissue in four patients with Huntington\u2019s disease: NEST-UK safety report ISRCTN no 36485475. J Neurol Neurosurg Psychiatry. 2002;73:678\u201385. https:\/\/doi.org\/10.1136\/jnnp.73.6.678.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"816_CR20","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jnnp-2012-302441","volume":"84","author":"RA Barker","year":"2013","unstructured":"Barker RA, Mason SL, Harrower TP, Swain RA, Ho AK, Sahakian BJ, et al. The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington\u2019s disease. J Neurol Neurosurg Psychiatry. 2013;84:657\u201365. https:\/\/doi.org\/10.1136\/jnnp-2012-302441.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"816_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","volume":"5","author":"A-C Bachoud-L\u00e9vi","year":"2006","unstructured":"Bachoud-L\u00e9vi A-C, Gaura V, Brugi\u00e8res P, Lefaucheur J-P, Boiss\u00e9 M-F, Maison P, et al. Effect of fetal neural transplants in patients with Huntington\u2019s disease 6 years after surgery: a long-term follow-up study. Lancet Neurol. 2006;5:303\u20139. https:\/\/doi.org\/10.1016\/S1474-4422(06)70381-7.","journal-title":"Lancet Neurol"},{"key":"816_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.stemcr.2017.11.005","volume":"10","author":"JC Reidling","year":"2018","unstructured":"Reidling JC, Rela\u00f1o-Gin\u00e9s A, Holley SM, Ochaba J, Moore C, Fury B, et al. Human neural stem cell transplantation rescues functional deficits in R6\/2 and Q140 Huntington\u2019s disease mice. Stem Cell Rep. 2018;10:58\u201372. https:\/\/doi.org\/10.1016\/j.stemcr.2017.11.005.","journal-title":"Stem Cell Rep"},{"key":"816_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.irn.2022.09.003","volume":"166","author":"P Garcia Jare\u00f1o","year":"2022","unstructured":"Garcia Jare\u00f1o P, Bartley OJM, Precious SV, Rosser AE, Lelos MJ. Challenges in progressing cell therapies to the clinic for Huntington\u2019s disease: a review of the progress made with pluripotent stem cell derived medium spiny neurons. Int Rev Neurobiol. 2022;166:1\u201348. https:\/\/doi.org\/10.1016\/bs.irn.2022.09.003.","journal-title":"Int Rev Neurobiol"},{"key":"816_CR24","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145\u20137. https:\/\/doi.org\/10.1126\/science.282.5391.1145.","journal-title":"Science"},{"key":"816_CR25","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.stem.2023.08.014","volume":"30","author":"A Kirkeby","year":"2023","unstructured":"Kirkeby A, Nelander J, Hoban DB, Rogelius N, Bjartmarz H, Storm P, et al. Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson\u2019s disease, STEM-PD. Cell Stem Cell. 2023;30:1299-1314.e9. https:\/\/doi.org\/10.1016\/j.stem.2023.08.014.","journal-title":"Cell Stem Cell"},{"key":"816_CR26","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41586-025-08845-y","volume":"641","author":"V Tabar","year":"2025","unstructured":"Tabar V, Sarva H, Lozano AM, Fasano A, Kalia SK, Yu KKH, et al. Phase I trial of hES cell-derived dopaminergic neurons for Parkinson\u2019s disease. Nature. 2025;641:978\u201383. https:\/\/doi.org\/10.1038\/s41586-025-08845-y.","journal-title":"Nature"},{"key":"816_CR27","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41586-025-08700-0","volume":"641","author":"N Sawamoto","year":"2025","unstructured":"Sawamoto N, Doi D, Nakanishi E, Sawamura M, Kikuchi T, Yamakado H, et al. Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson\u2019s disease. Nature. 2025;641:971\u20137. https:\/\/doi.org\/10.1038\/s41586-025-08700-0.","journal-title":"Nature"},{"key":"816_CR28","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/jcb.22775","volume":"111","author":"C-Y Fong","year":"2010","unstructured":"Fong C-Y, Gauthaman K, Bongso A. Teratomas from pluripotent stem cells: a clinical hurdle. J Cell Biochem. 2010;111:769\u201381. https:\/\/doi.org\/10.1002\/jcb.22775.","journal-title":"J Cell Biochem"},{"key":"816_CR29","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.stem.2011.05.012","volume":"8","author":"CEP Goldring","year":"2011","unstructured":"Goldring CEP, Duffy PA, Benvenisty N, Andrews PW, Ben-David U, Eakins R, et al. Assessing the safety of stem cell therapeutics. Cell Stem Cell. 2011;8:618\u201328. https:\/\/doi.org\/10.1016\/j.stem.2011.05.012.","journal-title":"Cell Stem Cell"},{"key":"816_CR30","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1177\/0192623320918241","volume":"49","author":"R Haworth","year":"2021","unstructured":"Haworth R, Sharpe M. The role of immune tolerance in the development of stem cell therapies and possible future approaches. Toxicol Pathol. 2021;49:1308\u201316. https:\/\/doi.org\/10.1177\/0192623320918241.","journal-title":"Toxicol Pathol"},{"key":"816_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41536-021-00198-0","volume":"7","author":"HJ Park","year":"2022","unstructured":"Park HJ, Han A, Kim JY, Choi J, Bae HS, Cho G, et al. SUPT4H1-edited stem cell therapy rescues neuronal dysfunction in a mouse model for Huntington\u2019s disease. Npj Regen Med. 2022;7:8. https:\/\/doi.org\/10.1038\/s41536-021-00198-0.","journal-title":"Npj Regen Med"},{"key":"816_CR32","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/nprot.2008.92","volume":"3","author":"I-H Park","year":"2008","unstructured":"Park I-H, Lerou PH, Zhao R, Huo H, Daley GQ. Generation of human-induced pluripotent stem cells. Nat Protoc. 2008;3:1180\u20136. https:\/\/doi.org\/10.1038\/nprot.2008.92.","journal-title":"Nat Protoc"},{"key":"816_CR33","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.stemcr.2017.01.022","volume":"8","author":"X Xu","year":"2017","unstructured":"Xu X, Tay Y, Sim B, Yoon S-I, Huang Y, Ooi J, et al. Reversal of phenotypic abnormalities by CRISPR\/Cas9-mediated gene correction in Huntington disease patient-derived induced pluripotent stem cells. Stem Cell Reports. 2017;8:619\u201333. https:\/\/doi.org\/10.1016\/j.stemcr.2017.01.022.","journal-title":"Stem Cell Reports"},{"key":"816_CR34","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.3390\/cells11131984","volume":"11","author":"FJ Molina-Ruiz","year":"2022","unstructured":"Molina-Ruiz FJ, Introna C, Bombau G, Galofre M, Canals JM. Standardization of cell culture conditions and routine genomic screening under a quality management system leads to reduced genomic instability in hPSCs. Cells. 2022;11:1984. https:\/\/doi.org\/10.3390\/cells11131984.","journal-title":"Cells"},{"key":"816_CR35","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","volume":"22","author":"J Galipeau","year":"2018","unstructured":"Galipeau J, Sens\u00e9b\u00e9 L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018;22:824\u201333. https:\/\/doi.org\/10.1016\/j.stem.2018.05.004.","journal-title":"Cell Stem Cell"},{"key":"816_CR36","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.mayocp.2019.01.001","volume":"94","author":"NP Staff","year":"2019","unstructured":"Staff NP, Jones DT, Singer W. Mesenchymal stromal cell therapies for neurodegenerative diseases. Mayo Clin Proc. 2019;94:892\u2013905. https:\/\/doi.org\/10.1016\/j.mayocp.2019.01.001.","journal-title":"Mayo Clin Proc"},{"key":"816_CR37","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/sctm.19-0430","volume":"9","author":"B Badyra","year":"2020","unstructured":"Badyra B, Su\u0142kowski M, Milczarek O, Majka M. Mesenchymal stem cells as a multimodal treatment for nervous system diseases. Stem Cells Transl Med. 2020;9:1174\u201389. https:\/\/doi.org\/10.1002\/sctm.19-0430.","journal-title":"Stem Cells Transl Med"},{"key":"816_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184597","volume":"20","author":"S Eleuteri","year":"2019","unstructured":"Eleuteri S, Fierabracci A. Insights into the secretome of mesenchymal stem cells and its potential applications. Int J Mol Sci. 2019;20:4597. https:\/\/doi.org\/10.3390\/ijms20184597.","journal-title":"Int J Mol Sci"},{"key":"816_CR39","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1182\/blood-2006-10-051060","volume":"109","author":"C Ries","year":"2007","unstructured":"Ries C, Egea V, Karow M, Kolb H, Jochum M, Neth P. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood. 2007;109:4055\u201363. https:\/\/doi.org\/10.1182\/blood-2006-10-051060.","journal-title":"Blood"},{"key":"816_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-1-4939-8697-2_6","volume":"1842","author":"P Conaty","year":"2018","unstructured":"Conaty P, Sherman LS, Naaldijk Y, Ulrich H, Stolzing A, Rameshwar P. Methods of mesenchymal stem cell homing to the blood-brain barrier. Methods Mol Biol Clifton NJ. 2018;1842:81\u201391. https:\/\/doi.org\/10.1007\/978-1-4939-8697-2_6.","journal-title":"Methods Mol Biol Clifton NJ."},{"key":"816_CR41","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1523\/JNEUROSCI.20-16-06063.2000","volume":"20","author":"O Mar\u00edn","year":"2000","unstructured":"Mar\u00edn O, Anderson SA, Rubenstein JLR. Origin and molecular specification of striatal interneurons. J Neurosci. 2000;20:6063\u201376. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-16-06063.2000.","journal-title":"J Neurosci"},{"key":"816_CR42","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1523\/JNEUROSCI.23-01-00167.2003","volume":"23","author":"J Stenman","year":"2003","unstructured":"Stenman J, Toresson H, Campbell K. Identification of two distinct progenitor populations in the lateral ganglionic eminence: implications for striatal and olfactory bulb neurogenesis. J Neurosci. 2003;23:167\u201374. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-01-00167.2003.","journal-title":"J Neurosci"},{"key":"816_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/bs.pbr.2016.12.011","volume":"230","author":"A-C Bachoud-L\u00e9vi","year":"2017","unstructured":"Bachoud-L\u00e9vi A-C. From open to large-scale randomized cell transplantation trials in Huntington\u2019s disease: lessons from the multicentric intracerebral grafting in Huntington\u2019s disease trial (MIG-HD) and previous pilot studies. Prog Brain Res. 2017;230:227\u201361. https:\/\/doi.org\/10.1016\/bs.pbr.2016.12.011.","journal-title":"Prog Brain Res"},{"key":"816_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/exnr.1997.6685","volume":"149","author":"OV Kopyov","year":"1998","unstructured":"Kopyov OV, Jacques S, Lieberman A, Duma CM, Eagle KS. Safety of intrastriatal neurotransplantation for Huntington\u2019s disease patients. Exp Neurol. 1998;149:97\u2013108. https:\/\/doi.org\/10.1006\/exnr.1997.6685.","journal-title":"Exp Neurol"},{"key":"816_CR45","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1006\/exnr.1999.7239","volume":"161","author":"A Bachoud-L\u00e9vi","year":"2000","unstructured":"Bachoud-L\u00e9vi A, Bourdet C, Brugi\u00e8res P, Nguyen JP, Grandmougin T, Haddad B, et al. Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington\u2019s disease. Exp Neurol. 2000;161:194\u2013202. https:\/\/doi.org\/10.1006\/exnr.1999.7239.","journal-title":"Exp Neurol"},{"key":"816_CR46","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1212\/wnl.58.5.687","volume":"58","author":"RA Hauser","year":"2002","unstructured":"Hauser RA, Furtado S, Cimino CR, Delgado H, Eichler S, Schwartz S, et al. Bilateral human fetal striatal transplantation in Huntington\u2019s disease. Neurology. 2002;58:687\u201395. https:\/\/doi.org\/10.1212\/wnl.58.5.687.","journal-title":"Neurology"},{"key":"816_CR47","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1212\/01.wnl.0000264504.14301.f5","volume":"68","author":"CD Keene","year":"2007","unstructured":"Keene CD, Sonnen JA, Swanson PD, Kopyov O, Leverenz JB, Bird TD, et al. Neural transplantation in Huntington disease: long-term grafts in two patients. Neurology. 2007;68:2093\u20138. https:\/\/doi.org\/10.1212\/01.wnl.0000264504.14301.f5.","journal-title":"Neurology"},{"issue":"11","key":"816_CR48","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S1474-4422(09)70278-9","volume":"8","author":"A-C Bachoud-L\u00e9vi","year":"2009","unstructured":"Bachoud-L\u00e9vi A-C. Neural grafts in Huntington\u2019s disease: viability after 10 years. Lancet Neurol. 2009;8(11):979\u201381. https:\/\/doi.org\/10.1016\/S1474-4422(09)70278-9.","journal-title":"Lancet Neurol"},{"key":"816_CR49","doi-asserted-by":"publisher","first-page":"12483","DOI":"10.1073\/pnas.0904239106","volume":"106","author":"F Cicchetti","year":"2009","unstructured":"Cicchetti F, Saporta S, Hauser RA, Parent M, Saint-Pierre M, Sanberg PR, et al. Neural transplants in patients with Huntington\u2019s disease undergo disease-like neuronal degeneration. Proc Natl Acad Sci U S A. 2009;106:12483\u20138. https:\/\/doi.org\/10.1073\/pnas.0904239106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"816_CR50","doi-asserted-by":"publisher","first-page":"13877","DOI":"10.1073\/pnas.97.25.13877","volume":"97","author":"TB Freeman","year":"2000","unstructured":"Freeman TB, Cicchetti F, Hauser RA, Deacon TW, Li XJ, Hersch SM, et al. Transplanted fetal striatum in Huntington\u2019s disease: phenotypic development and lack of pathology. Proc Natl Acad Sci U S A. 2000;97:13877\u201382. https:\/\/doi.org\/10.1073\/pnas.97.25.13877.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"816_CR51","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00401-008-0465-0","volume":"117","author":"CD Keene","year":"2009","unstructured":"Keene CD, Chang RC, Leverenz JB, Kopyov O, Perlman S, Hevner RF, et al. A patient with Huntington\u2019s disease and long-surviving fetal neural transplants that developed mass lesions. Acta Neuropathol (Berl). 2009;117:329\u201338. https:\/\/doi.org\/10.1007\/s00401-008-0465-0.","journal-title":"Acta Neuropathol (Berl)."},{"issue":"8","key":"816_CR52","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1136\/jnnp.2007.142380","volume":"79","author":"I Reuter","year":"2008","unstructured":"Reuter I, Tai YF, Pavese N, Chaudhuri KR, Mason S, Polkey CE, et al. Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington\u2019s disease. J Neurol Neurosurg Psychiatry. 2008;79(8):948\u201351. https:\/\/doi.org\/10.1136\/jnnp.2007.142380.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"816_CR53","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/jnnp-2013-306533","volume":"85","author":"M Paganini","year":"2014","unstructured":"Paganini M, Biggeri A, Romoli AM, Mechi C, Ghelli E, Berti V, et al. Fetal striatal grafting slows motor and cognitive decline of Huntington\u2019s disease. J Neurol Neurosurg Psychiatry. 2014;85:974\u201381. https:\/\/doi.org\/10.1136\/jnnp-2013-306533.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"816_CR54","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.expneurol.2008.06.003","volume":"213","author":"P Gallina","year":"2008","unstructured":"Gallina P, Paganini M, Lombardini L, Saccardi R, Marini M, De Cristofaro MT, et al. Development of human striatal anlagen after transplantation in a patient with Huntington\u2019s disease. Exp Neurol. 2008;213:241\u20134. https:\/\/doi.org\/10.1016\/j.expneurol.2008.06.003.","journal-title":"Exp Neurol"},{"key":"816_CR55","unstructured":"Azidus Brasil. First in human study to evaluate safety of Cellavita HD investigational product after intravenous application in participants with Huntington\u2019s disease [Internet]. clinicaltrials.gov; 2022 Nov. Report No.: NCT02728115. https:\/\/clinicaltrials.gov\/study\/NCT02728115."},{"key":"816_CR56","unstructured":"Azidus Brasil. Dose-response evaluation of the investigational product Cellavita HD after intravenous administration in patients with Huntington\u2019s disease [Internet]. clinicaltrials.gov; 2022 Oct. Report No.: NCT03252535. https:\/\/clinicaltrials.gov\/study\/NCT03252535."},{"key":"816_CR57","unstructured":"Azidus Brasil. Clinical extension study for assessing the safety and efficacy of the intravenous administration of Cellavita-HD in Huntington\u2019s disease patients who participated in the ADORE-DH study. [Internet]. clinicaltrials.gov; 2022 Oct. Report No.: NCT04219241. https:\/\/clinicaltrials.gov\/study\/NCT04219241."},{"key":"816_CR58","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/gt.2010.71","volume":"17","author":"A Giralt","year":"2010","unstructured":"Giralt A, Friedman HC, Caneda-Ferr\u00f3n B, Urb\u00e1n N, Moreno E, Rubio N, et al. BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington\u2019s disease. Gene Ther. 2010;17:1294\u2013308. https:\/\/doi.org\/10.1038\/gt.2010.71.","journal-title":"Gene Ther"},{"key":"816_CR59","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","volume":"24","author":"JM Canals","year":"2004","unstructured":"Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Mart\u00edn-Iba\u00f1ez R, Mu\u00f1oz MT, et al. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington\u2019s disease. J Neurosci. 2004;24:7727\u201339. https:\/\/doi.org\/10.1523\/JNEUROSCI.1197-04.2004.","journal-title":"J Neurosci"},{"key":"816_CR60","unstructured":"Azidus Brasil. Phase III Efficacy and safety of NestaCell\u00ae in moderated Huntington\u2019s disease [Internet]. clinicaltrials.gov; 2023 Oct. Report No.: NCT06097780. https:\/\/clinicaltrials.gov\/study\/NCT06097780."},{"key":"816_CR61","doi-asserted-by":"publisher","unstructured":"Huntington\u2019s disease clinical trials update: March 2025 - Mena Farag, Sarah J Tabrizi, Edward J Wild, 2025 [Internet]. [cited 2025 May 6]. https:\/\/journals-sagepub-com.sire.ub.edu\/doi\/, https:\/\/doi.org\/10.1177\/18796397251337000.","DOI":"10.1177\/18796397251337000"},{"key":"816_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41536-019-0066-7","volume":"4","author":"IK Cho","year":"2019","unstructured":"Cho IK, Hunter CE, Ye S, Pongos AL, Chan AWS. Combination of stem cell and gene therapy ameliorates symptoms in Huntington\u2019s disease mice. Npj Regen Med. 2019;4:1\u20139. https:\/\/doi.org\/10.1038\/s41536-019-0066-7.","journal-title":"Npj Regen Med."},{"key":"816_CR63","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/ana.21788","volume":"66","author":"S-T Lee","year":"2009","unstructured":"Lee S-T, Chu K, Jung K-H, Im W-S, Park J-E, Lim H-C, et al. Slowed progression in models of Huntington disease by adipose stem cell transplantation. Ann Neurol. 2009;66:671\u201381. https:\/\/doi.org\/10.1002\/ana.21788.","journal-title":"Ann Neurol"},{"key":"816_CR64","unstructured":"Welter R. Use Of autologous stem cell use in neurological non-neoplastic disorders and disease [Internet]. clinicaltrials.gov; 2018 Oct. Report No.: NCT03297177. https:\/\/clinicaltrials.gov\/study\/NCT03297177."},{"key":"816_CR65","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1590\/s1980-5764-2016dn1004006","volume":"10","author":"MS Haddad","year":"2016","unstructured":"Haddad MS, Wenceslau CV, Pompeia C, Kerkis I. Cell-based technologies for Huntington\u2019s disease. Dement Neuropsychol. 2016;10:287\u201395. https:\/\/doi.org\/10.1590\/s1980-5764-2016dn1004006.","journal-title":"Dement Neuropsychol"},{"key":"816_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022924","volume":"6","author":"Y-T Lin","year":"2011","unstructured":"Lin Y-T, Chern Y, Shen C-KJ, Wen H-L, Chang Y-C, Li H, et al. Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington\u2019s disease mouse models. PLoS ONE. 2011;6:e22924. https:\/\/doi.org\/10.1371\/journal.pone.0022924.","journal-title":"PLoS ONE"},{"key":"816_CR67","doi-asserted-by":"publisher","first-page":"RRN1183","DOI":"10.1371\/currents.RRN1183","volume":"2","author":"W Im","year":"2010","unstructured":"Im W, Lee S-T, Park JE, Oh hyun J, Shim J, Lim J, et al. Transplantation of patient-derived adipose stem cells in YAC128 Huntington\u2019s disease transgenic mice. PLoS Curr. 2010;2:RRN1183. https:\/\/doi.org\/10.1371\/currents.RRN1183.","journal-title":"PLoS Curr."},{"key":"816_CR68","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/scrt341","volume":"4","author":"KD Fink","year":"2013","unstructured":"Fink KD, Rossignol J, Crane AT, Davis KK, Bombard MC, Bavar AM, et al. Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6\/2 mice: behavioral and neuropathological analysis. Stem Cell Res Ther. 2013;4:130. https:\/\/doi.org\/10.1186\/scrt341.","journal-title":"Stem Cell Res Ther"},{"key":"816_CR69","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/scrt545","volume":"6","author":"J Rossignol","year":"2015","unstructured":"Rossignol J, Fink KD, Crane AT, Davis KK, Bombard MC, Clerc S, et al. Reductions in behavioral deficits and neuropathology in the R6\/2 mouse model of Huntington\u2019s disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number. Stem Cell Res Ther. 2015;6:9. https:\/\/doi.org\/10.1186\/scrt545.","journal-title":"Stem Cell Res Ther"},{"key":"816_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009347","volume":"5","author":"BR Snyder","year":"2010","unstructured":"Snyder BR, Chiu AM, Prockop DJ, Chan AWS. Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington\u2019s disease. PLoS ONE. 2010;5:e9347. https:\/\/doi.org\/10.1371\/journal.pone.0009347.","journal-title":"PLoS ONE"},{"key":"816_CR71","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bbr.2010.05.023","volume":"214","author":"ND Dey","year":"2010","unstructured":"Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, Rossignol J, et al. Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington\u2019s disease. Behav Brain Res. 2010;214:193\u2013200. https:\/\/doi.org\/10.1016\/j.bbr.2010.05.023.","journal-title":"Behav Brain Res"},{"key":"816_CR72","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12640-018-9884-4","volume":"34","author":"MJ Ebrahimi","year":"2018","unstructured":"Ebrahimi MJ, Aliaghaei A, Boroujeni ME, Khodagholi F, Meftahi G, Abdollahifar MA, et al. Human umbilical cord matrix stem cells reverse oxidative stress-induced cell death and ameliorate motor function and striatal atrophy in rat model of Huntington disease. Neurotox Res. 2018;34:273\u201384. https:\/\/doi.org\/10.1007\/s12640-018-9884-4.","journal-title":"Neurotox Res"},{"key":"816_CR73","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.bbr.2010.11.006","volume":"217","author":"J Rossignol","year":"2011","unstructured":"Rossignol J, Boyer C, L\u00e9v\u00e8que X, Fink KD, Thinard R, Blanchard F, et al. Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington\u2019s disease: morphological and behavioral outcomes. Behav Brain Res. 2011;217:369\u201378. https:\/\/doi.org\/10.1016\/j.bbr.2010.11.006.","journal-title":"Behav Brain Res"},{"key":"816_CR74","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0306-4522(97)00532-0","volume":"84","author":"M Olsson","year":"1998","unstructured":"Olsson M, Bj\u00f6rklund A, Campbell K. Early specification of striatal projection neurons and interneuronal subtypes in the lateral and medial ganglionic eminence. Neuroscience. 1998;84:867\u201376. https:\/\/doi.org\/10.1016\/S0306-4522(97)00532-0.","journal-title":"Neuroscience"},{"key":"816_CR75","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008094","volume":"4","author":"SJ Harrison-Uy","year":"2012","unstructured":"Harrison-Uy SJ, Pleasure SJ. Wnt signaling and forebrain development. Cold Spring Harb Perspect Biol. 2012;4:a008094. https:\/\/doi.org\/10.1101\/cshperspect.a008094.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"816_CR76","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1529","volume":"27","author":"SM Chambers","year":"2009","unstructured":"Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol. 2009;27:275\u201380. https:\/\/doi.org\/10.1038\/nbt.1529.","journal-title":"Nat Biotechnol"},{"key":"816_CR77","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/stem.1462","volume":"31","author":"C Nicoleau","year":"2013","unstructured":"Nicoleau C, Varela C, Bonnefond C, Maury Y, Bugi A, Aubry L, et al. Embryonic stem cells neural differentiation qualifies the role of Wnt\/\u03b2-catenin signals in human telencephalic specification and regionalization. Stem Cells. 2013;31:1763\u201374. https:\/\/doi.org\/10.1002\/stem.1462.","journal-title":"Stem Cells"},{"key":"816_CR78","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.stemcr.2018.03.007","volume":"10","author":"MM Adil","year":"2018","unstructured":"Adil MM, Gaj T, Rao AT, Kulkarni RU, Fuentes CM, Ramadoss GN, et al. hPSC-derived striatal cells generated using a scalable 3D hydrogel promote recovery in a Huntington disease mouse model. Stem Cell Reports. 2018;10:1481\u201391. https:\/\/doi.org\/10.1016\/j.stemcr.2018.03.007.","journal-title":"Stem Cell Reports"},{"key":"816_CR79","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.stemcr.2018.08.005","volume":"11","author":"M Wu","year":"2018","unstructured":"Wu M, Zhang D, Bi C, Mi T, Zhu W, Xia L, et al. A chemical recipe for generation of clinical-grade striatal neurons from hESCs. Stem Cell Reports. 2018;11:635\u201350. https:\/\/doi.org\/10.1016\/j.stemcr.2018.08.005.","journal-title":"Stem Cell Reports"},{"key":"816_CR80","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.stemcr.2020.01.015","volume":"14","author":"C Smith-Geater","year":"2020","unstructured":"Smith-Geater C, Hernandez SJ, Lim RG, Adam M, Wu J, Stocksdale JT, et al. Aberrant development corrected in adult-onset Huntington\u2019s disease iPSC-derived neuronal cultures via Wnt signaling modulation. Stem Cell Reports. 2020;14:406\u201319. https:\/\/doi.org\/10.1016\/j.stemcr.2020.01.015.","journal-title":"Stem Cell Reports"},{"key":"816_CR81","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.stemcr.2020.03.018","volume":"14","author":"D Besusso","year":"2020","unstructured":"Besusso D, Schellino R, Boido M, Belloli S, Parolisi R, Conforti P, et al. Stem cell-derived human striatal progenitors innervate striatal targets and alleviate sensorimotor deficit in a rat model of Huntington disease. Stem Cell Reports. 2020;14:876\u201391. https:\/\/doi.org\/10.1016\/j.stemcr.2020.03.018.","journal-title":"Stem Cell Reports"},{"key":"816_CR82","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1007\/s12035-020-01907-4","volume":"57","author":"A Comella-Bolla","year":"2020","unstructured":"Comella-Bolla A, Orlandi JG, Miguez A, Straccia M, Garc\u00eda-Bravo M, Bombau G, et al. Human pluripotent stem cell-derived neurons are functionally mature in vitro and integrate into the mouse striatum following transplantation. Mol Neurobiol. 2020;57:2766\u201398. https:\/\/doi.org\/10.1007\/s12035-020-01907-4.","journal-title":"Mol Neurobiol"},{"key":"816_CR83","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1242\/dev.117093","volume":"142","author":"C Arber","year":"2015","unstructured":"Arber C, Precious SV, Cambray S, Risner-Janiczek JR, Kelly C, Noakes Z, et al. Activin A directs striatal projection neuron differentiation of human pluripotent stem cells. Development. 2015;142:1375\u201386. https:\/\/doi.org\/10.1242\/dev.117093.","journal-title":"Development"},{"key":"816_CR84","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","volume":"11","author":"MC An","year":"2012","unstructured":"An MC, Zhang N, Scott G, Montoro D, Wittkop T, Mooney S, et al. Genetic correction of Huntington\u2019s disease phenotypes in induced pluripotent stem cells. Cell Stem Cell. 2012;11:253\u201363. https:\/\/doi.org\/10.1016\/j.stem.2012.04.026.","journal-title":"Cell Stem Cell"},{"key":"816_CR85","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1002\/stem.1135","volume":"30","author":"I Jeon","year":"2012","unstructured":"Jeon I, Lee N, Li J-Y, Park I-H, Park KS, Moon J, et al. Neuronal properties, in vivo effects, and pathology of a Huntington\u2019s disease patient-derived induced pluripotent stem cells. Stem Cells. 2012;30:2054\u201362. https:\/\/doi.org\/10.1002\/stem.1135.","journal-title":"Stem Cells"},{"key":"816_CR86","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/34848","volume":"391","author":"A Glinka","year":"1998","unstructured":"Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature. 1998;391:357\u201362. https:\/\/doi.org\/10.1038\/34848.","journal-title":"Nature"},{"key":"816_CR87","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1242\/dev.128.21.4189","volume":"128","author":"C Kiecker","year":"2001","unstructured":"Kiecker C, Niehrs C. A morphogen gradient of Wnt\/beta-catenin signalling regulates anteroposterior neural patterning in Xenopus. Dev Camb Engl. 2001;128:4189\u2013201. https:\/\/doi.org\/10.1242\/dev.128.21.4189.","journal-title":"Dev Camb Engl."},{"key":"816_CR88","doi-asserted-by":"publisher","first-page":"16707","DOI":"10.1073\/pnas.0808488105","volume":"105","author":"L Aubry","year":"2008","unstructured":"Aubry L, Bugi A, Lefort N, Rousseau F, Peschanski M, Perrier AL. Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proc Natl Acad Sci U S A. 2008;105:16707. https:\/\/doi.org\/10.1073\/pnas.0808488105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"816_CR89","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1242\/dev.124.14.2709","volume":"124","author":"K Shimamura","year":"1997","unstructured":"Shimamura K, Rubenstein JL. Inductive interactions direct early regionalization of the mouse forebrain. Development. 1997;124:2709\u201318. https:\/\/doi.org\/10.1242\/dev.124.14.2709.","journal-title":"Development"},{"key":"816_CR90","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.stem.2012.01.021","volume":"10","author":"L Ma","year":"2012","unstructured":"Ma L, Hu B, Liu Y, Vermilyea SC, Liu H, Gao L, et al. Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice. Cell Stem Cell. 2012;10:455\u201364. https:\/\/doi.org\/10.1016\/j.stem.2012.01.021.","journal-title":"Cell Stem Cell"},{"key":"816_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11123331","volume":"11","author":"G Nittari","year":"2023","unstructured":"Nittari G, Roy P, Martinelli I, Bellitto V, Tomassoni D, Traini E, et al. Rodent models of Huntington\u2019s disease: an overview. Biomedicines. 2023;11:3331. https:\/\/doi.org\/10.3390\/biomedicines11123331.","journal-title":"Biomedicines"},{"key":"816_CR92","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1242\/dev.084608","volume":"140","author":"A Delli Carri","year":"2013","unstructured":"Delli Carri A, Onorati M, Lelos MJ, Castiglioni V, Faedo A, Menon R, et al. Developmentally coordinated extrinsic signals drive human pluripotent stem cell differentiation toward authentic DARPP-32+ medium-sized spiny neurons. Development. 2013;140:301\u201312. https:\/\/doi.org\/10.1242\/dev.084608.","journal-title":"Development"},{"key":"816_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03422-4","volume":"14","author":"R Schellino","year":"2023","unstructured":"Schellino R, Besusso D, Parolisi R, G\u00f3mez-Gonz\u00e1lez GB, Dallere S, Scaramuzza L, et al. hESC-derived striatal progenitors grafted into a Huntington\u2019s disease rat model support long-term functional motor recovery by differentiating, self-organizing and connecting into the lesioned striatum. Stem Cell Res Ther. 2023;14:189. https:\/\/doi.org\/10.1186\/s13287-023-03422-4.","journal-title":"Stem Cell Res Ther"},{"key":"816_CR94","doi-asserted-by":"publisher","first-page":"43","DOI":"10.15283\/ijsc.2014.7.1.43","volume":"7","author":"I Jeon","year":"2014","unstructured":"Jeon I, Choi C, Lee N, Im W, Kim M, Oh S-H, et al. In vivo roles of a patient-derived induced pluripotent stem cell line (HD72-iPSC) in the YAC128 model of Huntington\u2019s disease. Int J Stem Cells. 2014;7:43\u20137. https:\/\/doi.org\/10.15283\/ijsc.2014.7.1.43.","journal-title":"Int J Stem Cells"},{"key":"816_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.106905","volume":"209","author":"FJ Molina-Ruiz","year":"2025","unstructured":"Molina-Ruiz FJ, Sanders P, Gomis C, Abante J, Londo\u00f1o F, Bombau G, et al. CD200-based cell sorting results in homogeneous transplantable striatal neuroblasts for human cell therapy for Huntington\u2019s disease. Neurobiol Dis. 2025;209:106905. https:\/\/doi.org\/10.1016\/j.nbd.2025.106905.","journal-title":"Neurobiol Dis"},{"key":"816_CR96","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-201x.1971.tb10999.x","author":"U Ungerstedt","year":"1971","unstructured":"Ungerstedt U. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol Scand Suppl. 1971. https:\/\/doi.org\/10.1111\/j.1365-201x.1971.tb10999.x.","journal-title":"Acta Physiol Scand Suppl"},{"key":"816_CR97","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.bbr.2007.02.030","volume":"179","author":"MD D\u00f6br\u00f6ssy","year":"2007","unstructured":"D\u00f6br\u00f6ssy MD, Dunnett SB. The corridor task: striatal lesion effects and graft-mediated recovery in a model of Huntington\u2019s disease. Behav Brain Res. 2007;179:326\u201330. https:\/\/doi.org\/10.1016\/j.bbr.2007.02.030.","journal-title":"Behav Brain Res"},{"key":"816_CR98","doi-asserted-by":"publisher","first-page":"10524","DOI":"10.1073\/pnas.96.18.10524","volume":"96","author":"PJ Brasted","year":"1999","unstructured":"Brasted PJ, Watts C, Robbins TW, Dunnett SB. Associative plasticity in striatal transplants. Proc Natl Acad Sci U S A. 1999;96:10524\u20139. https:\/\/doi.org\/10.1073\/pnas.96.18.10524.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"816_CR99","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s002210050877","volume":"128","author":"PJ Brasted","year":"1999","unstructured":"Brasted PJ, Watts C, Torres EM, Robbins TW, Dunnett SB. Behavioural recovery following striatal transplantation: effects of postoperative training and P-zone volume. Exp Brain Res. 1999;128:535\u20138. https:\/\/doi.org\/10.1007\/s002210050877.","journal-title":"Exp Brain Res"},{"key":"816_CR100","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00018-023-04882-w","volume":"80","author":"A Miguez","year":"2023","unstructured":"Miguez A, Gomis C, Vila C, Mongui\u00f3-Tortajada M, Fern\u00e1ndez-Garc\u00eda S, Bombau G, et al. Soluble mutant huntingtin drives early human pathogenesis in Huntington\u2019s disease. Cell Mol Life Sci. 2023;80:238. https:\/\/doi.org\/10.1007\/s00018-023-04882-w.","journal-title":"Cell Mol Life Sci"},{"key":"816_CR101","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/ana.24174","volume":"76","author":"F Cicchetti","year":"2014","unstructured":"Cicchetti F, Lacroix S, Cisbani G, Valli\u00e8res N, Saint-Pierre M, St-Amour I, et al. Mutant huntingtin is present in neuronal grafts in Huntington disease patients. Ann Neurol. 2014;76:31\u201342. https:\/\/doi.org\/10.1002\/ana.24174.","journal-title":"Ann Neurol"},{"key":"816_CR102","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/ana.25354","volume":"84","author":"A Maxan","year":"2018","unstructured":"Maxan A, Mason S, Saint-Pierre M, Smith E, Ho A, Harrower T, et al. Outcome of cell suspension allografts in a patient with Huntington\u2019s disease. Ann Neurol. 2018;84:950\u20136. https:\/\/doi.org\/10.1002\/ana.25354.","journal-title":"Ann Neurol"},{"key":"816_CR103","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neulet.2007.05.066","volume":"423","author":"J Song","year":"2007","unstructured":"Song J, Lee S-T, Kang W, Park J-E, Chu K, Lee S, et al. Human embryonic stem cell-derived neural precursor transplants attenuate apomorphine-induced rotational behavior in rats with unilateral quinolinic acid lesions. Neurosci Lett. 2007;423:58\u201361. https:\/\/doi.org\/10.1016\/j.neulet.2007.05.066.","journal-title":"Neurosci Lett"},{"key":"816_CR104","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13082","volume":"54","author":"HJ Park","year":"2021","unstructured":"Park HJ, Jeon J, Choi J, Kim JY, Kim HS, Huh JY, et al. Human iPSC-derived neural precursor cells differentiate into multiple cell types to delay disease progression following transplantation into YAC128 Huntington\u2019s disease mouse model. Cell Prolif. 2021;54:e13082. https:\/\/doi.org\/10.1111\/cpr.13082.","journal-title":"Cell Prolif"},{"key":"816_CR105","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1016\/j.ymthe.2023.10.003","volume":"31","author":"SM Holley","year":"2023","unstructured":"Holley SM, Reidling JC, Cepeda C, Wu J, Lim RG, Lau A, et al. Transplanted human neural stem cells rescue phenotypes in zQ175 Huntington\u2019s disease mice and innervate the striatum. Mol Ther. 2023;31:3545\u201363. https:\/\/doi.org\/10.1016\/j.ymthe.2023.10.003.","journal-title":"Mol Ther"},{"key":"816_CR106","doi-asserted-by":"publisher","first-page":"11758","DOI":"10.1038\/ncomms11758","volume":"7","author":"A Benraiss","year":"2016","unstructured":"Benraiss A, Wang S, Herrlinger S, Li X, Chandler-Militello D, Mauceri J, et al. Human glia can both induce and rescue aspects of disease phenotype in Huntington disease. Nat Commun. 2016;7:11758. https:\/\/doi.org\/10.1038\/ncomms11758.","journal-title":"Nat Commun"},{"key":"816_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115762","volume":"44","author":"CB Villanueva","year":"2025","unstructured":"Villanueva CB, Huynh NPT, Mariani JN, Mansky B, Tate A, Lorenzen SS, et al. Human glial progenitors transplanted into Huntington disease mice normalize neuronal gene expression, dendritic structure, and behavior. Cell Rep. 2025;44:115762. https:\/\/doi.org\/10.1016\/j.celrep.2025.115762.","journal-title":"Cell Rep"},{"key":"816_CR108","doi-asserted-by":"publisher","first-page":"162","DOI":"10.46582\/jsrm.0803009","volume":"8","author":"C Maucksch","year":"2012","unstructured":"Maucksch C, Firmin E, Butler-Munro C, Montgomery J, Dottori M, Connor B. Non-viral generation of neural precursor-like cells from adult human fibroblasts. J Stem Cells Regen Med. 2012;8:162\u201370. https:\/\/doi.org\/10.46582\/jsrm.0803009.","journal-title":"J Stem Cells Regen Med"},{"key":"816_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2018.e00918","volume":"4","author":"B Connor","year":"2018","unstructured":"Connor B, Firmin E, McCaughey-Chapman A, Monk R, Lee K, Liot S, et al. Conversion of adult human fibroblasts into neural precursor cells using chemically modified mRNA. Heliyon. 2018;4:e00918. https:\/\/doi.org\/10.1016\/j.heliyon.2018.e00918.","journal-title":"Heliyon"},{"key":"816_CR110","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1002\/stem.3420","volume":"39","author":"R Monk","year":"2021","unstructured":"Monk R, Lee K, Jones KS, Connor B. Directly reprogrammed Huntington\u2019s disease neural precursor cells generate striatal neurons exhibiting aggregates and impaired neuronal maturation. Stem Cells. 2021;39:1410\u201322. https:\/\/doi.org\/10.1002\/stem.3420.","journal-title":"Stem Cells"},{"key":"816_CR111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109621","volume":"9","author":"Y Liu","year":"2014","unstructured":"Liu Y, Xue Y, Ridley S, Zhang D, Rezvani K, Fu X-D, et al. Direct reprogramming of Huntington\u2019s disease patient fibroblasts into neuron-like cells leads to abnormal neurite outgrowth, increased cell death, and aggregate formation. PLoS ONE. 2014;9:e109621. https:\/\/doi.org\/10.1371\/journal.pone.0109621.","journal-title":"PLoS ONE"},{"key":"816_CR112","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.cell.2012.11.045","volume":"152","author":"Y Xue","year":"2013","unstructured":"Xue Y, Ouyang K, Huang J, Zhou Y, Ouyang H, Li H, et al. Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. Cell. 2013;152:82\u201396. https:\/\/doi.org\/10.1016\/j.cell.2012.11.045.","journal-title":"Cell"},{"key":"816_CR113","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.neuron.2014.10.016","volume":"84","author":"MB Victor","year":"2014","unstructured":"Victor MB, Richner M, Hermanstyne TO, Ransdell JL, Sobieski C, Deng P-Y, et al. Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblasts. Neuron. 2014;84:311\u201323. https:\/\/doi.org\/10.1016\/j.neuron.2014.10.016.","journal-title":"Neuron"},{"key":"816_CR114","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41467-020-14855-3","volume":"11","author":"Z Wu","year":"2020","unstructured":"Wu Z, Parry M, Hou X-Y, Liu M-H, Wang H, Cain R, et al. Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington\u2019s disease. Nat Commun. 2020;11:1105. https:\/\/doi.org\/10.1038\/s41467-020-14855-3.","journal-title":"Nat Commun"},{"key":"816_CR115","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1016\/j.cell.2021.09.005","volume":"184","author":"L-L Wang","year":"2021","unstructured":"Wang L-L, Serrano C, Zhong X, Ma S, Zou Y, Zhang C-L. Revisiting astrocyte to neuron conversion with lineage tracing in vivo. Cell. 2021;184:5465-5481.e16. https:\/\/doi.org\/10.1016\/j.cell.2021.09.005.","journal-title":"Cell"},{"key":"816_CR116","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/nn.2385","volume":"12","author":"Z Gao","year":"2009","unstructured":"Gao Z, Ure K, Ables JL, Lagace DC, Nave K-A, Goebbels S, et al. Neurod1 is essential for the survival and maturation of adult-born neurons. Nat Neurosci. 2009;12:1090\u20132. https:\/\/doi.org\/10.1038\/nn.2385.","journal-title":"Nat Neurosci"},{"key":"816_CR117","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2107339119","volume":"119","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Li B, Cananzi S, Han C, Wang L-L, Zou Y, et al. A single factor elicits multilineage reprogramming of astrocytes in the adult mouse striatum. Proc Natl Acad Sci U S A. 2022;119:e2107339119. https:\/\/doi.org\/10.1073\/pnas.2107339119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"816_CR118","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3233\/JHD-210473","volume":"10","author":"SC4HD Consortium","year":"2021","unstructured":"SC4HD Consortium. Stem cells for Huntington\u2019s disease (SC4HD): an international consortium to facilitate stem cell-based therapy for\u00a0Huntington\u2019s disease. J Huntingt Dis. 2021;10:221\u20136. https:\/\/doi.org\/10.3233\/JHD-210473.","journal-title":"J Huntingt Dis."},{"key":"816_CR119","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1038\/s41598-021-85656-x","volume":"11","author":"K Le Cann","year":"2021","unstructured":"Le Cann K, Foerster A, R\u00f6sseler C, Erickson A, Hautvast P, Giesselmann S, et al. The difficulty to model Huntington\u2019s disease in vitro using striatal medium spiny neurons differentiated from human induced pluripotent stem cells. Sci Rep. 2021;11:6934. https:\/\/doi.org\/10.1038\/s41598-021-85656-x.","journal-title":"Sci Rep"},{"key":"816_CR120","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.neuroscience.2016.07.022","volume":"333","author":"M Straccia","year":"2016","unstructured":"Straccia M, Carrere J, Rosser AE, Canals JM. Human t-DARPP is induced during striatal development. Neuroscience. 2016;333:320\u201330. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.07.022.","journal-title":"Neuroscience"},{"key":"816_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00398","volume":"8","author":"AE Reddington","year":"2014","unstructured":"Reddington AE, Rosser AE, Dunnett SB. Differentiation of pluripotent stem cells into striatal projection neurons: a pure MSN fate may not be sufficient. Front Cell Neurosci. 2014;8:398. https:\/\/doi.org\/10.3389\/fncel.2014.00398.","journal-title":"Front Cell Neurosci"},{"key":"816_CR122","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1006\/exnr.1999.7341","volume":"163","author":"C Watts","year":"2000","unstructured":"Watts C, Brasted PJ, Dunnett SB. Embryonic donor age and dissection influences striatal graft development and functional integration in a rodent model of Huntington\u2019s disease. Exp Neurol. 2000;163:85\u201397. https:\/\/doi.org\/10.1006\/exnr.1999.7341.","journal-title":"Exp Neurol"},{"key":"816_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16225-5","author":"K Tiklova","year":"2020","unstructured":"Tiklova K, Nolbrant S, Fiorenzano A, Bj\u00f6rklund \u00c5K, Sharma Y, Heuer A, et al. Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson\u2019s disease. Nat Commun. 2020. https:\/\/doi.org\/10.1038\/s41467-020-16225-5.","journal-title":"Nat Commun"},{"key":"816_CR124","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.neuron.2019.10.002","volume":"104","author":"D Linaro","year":"2019","unstructured":"Linaro D, Vermaercke B, Iwata R, Ramaswamy A, Lib\u00e9-Philippot B, Boubakar L, et al. Xenotransplanted human cortical neurons reveal species-specific development and functional integration into mouse visual circuits. Neuron. 2019;104:972-986.e6. https:\/\/doi.org\/10.1016\/j.neuron.2019.10.002.","journal-title":"Neuron"},{"key":"816_CR125","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/096368979700600303","volume":"6","author":"LM Philpott","year":"1997","unstructured":"Philpott LM, Kopyov OV, Lee AJ, Jacques S, Duma CM, Caine S, et al. Neuropsychological functioning following fetal striatal transplantation in Huntington\u2019s chorea: three case presentations. Cell Transplant. 1997;6:203\u201312. https:\/\/doi.org\/10.1177\/096368979700600303.","journal-title":"Cell Transplant"},{"key":"816_CR126","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/(sici)1099-1492(199906)12:4<221::aid-nbm582>3.0.co;2-q","volume":"12","author":"BD Ross","year":"1999","unstructured":"Ross BD, Hoang TQ, Bl\u00fcml S, Dubowitz D, Kopyov OV, Jacques DB, et al. In vivo magnetic resonance spectroscopy of human fetal neural transplants. NMR Biomed. 1999;12:221\u201336. https:\/\/doi.org\/10.1002\/(sici)1099-1492(199906)12:4<221::aid-nbm582>3.0.co;2-q.","journal-title":"NMR Biomed"},{"key":"816_CR127","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/s0140-6736(00)03310-9","volume":"356","author":"AC Bachoud-L\u00e9vi","year":"2000","unstructured":"Bachoud-L\u00e9vi AC, R\u00e9my P, Nguyen JP, Brugi\u00e8res P, Lefaucheur JP, Bourdet C, et al. Motor and cognitive improvements in patients with Huntington\u2019s disease after neural transplantation. Lancet Lond Engl. 2000;356:1975\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(00)03310-9.","journal-title":"Lancet Lond Engl."},{"key":"816_CR128","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/brain\/awh003","volume":"127","author":"V Gaura","year":"2004","unstructured":"Gaura V, Bachoud-L\u00e9vi A-C, Ribeiro M-J, Nguyen J-P, Frouin V, Baudic S, et al. Striatal neural grafting improves cortical metabolism in Huntington\u2019s disease patients. Brain. 2004;127:65\u201372. https:\/\/doi.org\/10.1093\/brain\/awh003.","journal-title":"Brain"},{"key":"816_CR129","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/ana.20564","volume":"58","author":"S Furtado","year":"2005","unstructured":"Furtado S, Sossi V, Hauser RA, Samii A, Schulzer M, Murphy CB, et al. Positron emission tomography after fetal transplantation in Huntington\u2019s disease. Ann Neurol. 2005;58:331\u20137. https:\/\/doi.org\/10.1002\/ana.20564.","journal-title":"Ann Neurol"},{"key":"816_CR130","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/brain\/aws359","volume":"136","author":"G Cisbani","year":"2013","unstructured":"Cisbani G, Freeman TB, Soulet D, Saint-Pierre M, Gagnon D, Parent M, et al. Striatal allografts in patients with Huntington\u2019s disease: impact of diminished astrocytes and vascularization on graft viability. Brain. 2013;136:433\u201343. https:\/\/doi.org\/10.1093\/brain\/aws359.","journal-title":"Brain"},{"key":"816_CR131","doi-asserted-by":"publisher","DOI":"10.1371\/currents.hd.c0ad575f12106c38f9f5717a8a7d05ae","volume":"6","author":"M Mascalchi","year":"2014","unstructured":"Mascalchi M, Diciotti S, Paganini M, Bianchi A, Ginestroni A, Lombardini L, et al. Large-sized fetal striatal grafts in Huntington\u2019s disease do stop growing: long-term monitoring in the Florence experience. PLoS Curr. 2014;6:ecurrents.hd.c0ad575f12106c38f9f5717a8a7d05ae. https:\/\/doi.org\/10.1371\/currents.hd.c0ad575f12106c38f9f5717a8a7d05ae.","journal-title":"PLoS Curr"},{"key":"816_CR132","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3727\/096368913X676222","volume":"24","author":"B Porfirio","year":"2015","unstructured":"Porfirio B, Paganini M, Mazzanti B, Bagnoli S, Bucciantini S, Ghelli E, et al. Donor-specific anti-HLA antibodies in Huntington\u2019s disease recipients of human fetal striatal grafts. Cell Transplant. 2015;24:811\u20137. https:\/\/doi.org\/10.3727\/096368913X676222.","journal-title":"Cell Transplant"},{"key":"816_CR133","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1002\/mds.28201","volume":"35","author":"A-C Bachoud-L\u00e9vi","year":"2020","unstructured":"Bachoud-L\u00e9vi A-C, on behalf the Multicentric Intracerebral Grafting in Huntington\u2019s Disease Group. Human fetal cell therapy in Huntington\u2019s disease: a randomized, multicenter, phase II trial. Mov Disord Off J Mov Disord Soc. 2020;35:1323\u201335. https:\/\/doi.org\/10.1002\/mds.28201.","journal-title":"Mov Disord Off J Mov Disord Soc."},{"key":"816_CR134","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.neuroscience.2009.02.035","volume":"160","author":"P Capetian","year":"2009","unstructured":"Capetian P, Knoth R, Maciaczyk J, Pantazis G, Ditter M, Bokla L, et al. Histological findings on fetal striatal grafts in a Huntington\u2019s disease patient early after transplantation. Neuroscience. 2009;160:661\u201375. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.02.035.","journal-title":"Neuroscience"},{"issue":"2","key":"816_CR135","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3233\/RNN-130340","volume":"32","author":"WOC Lopez","year":"2014","unstructured":"Lopez WOC, Nikkhah G, Sch\u00fcltke E, Furlanetti L, Trippel M. Stereotactic planning software for human neurotransplantation: suitability in 22 surgical cases of Huntington\u2019s disease. Restor Neurol Neurosci. 2014;32(2):259\u201368. https:\/\/doi.org\/10.3233\/RNN-130340.","journal-title":"Restor Neurol Neurosci"}],"container-title":["Molecular Diagnosis &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-025-00816-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-025-00816-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-025-00816-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:52:32Z","timestamp":1769496752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-025-00816-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":135,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["816"],"URL":"https:\/\/doi.org\/10.1007\/s40291-025-00816-3","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was supported by grants from the Ministerio de Ciencia, Innovaci\u00f3n y Universidades (PID2021-126961OB-I00 and PDC2022-133783-I00); Instituto de Salud Carlos III, Ministerio de Ciencia, Innovaci\u00f3n y Universidades, and European Regional Development Fund (ERDF) (Red de Terapias Avanzadas, RD21\/0017\/0020 and RD24\/0014\/0016); European Union NextGenerationEU\/PRTR; and Generalitat de Catalunya (2021 SGR 01094), Spain. CG and ME are fellows of the Ministerio de Ciencia, Innovaci\u00f3n y Universidades.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"ME, CG, and JMC declare that they have no relevant financial or nonfinancial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have approved the content of the present manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Data sharing is not applicable to this review as no datasets were generated or analyzed during the current study.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"ME: conceptualization, data curation, writing (original draft, review and editing), CG: conceptualization, data curation, writing (original draft, review and editing), JMC: conceptualization, writing (review and editing), supervision and funding acquisition.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}